A group of strategy consultants at Azabu Insights, Tokyo, Japan have been analyzing the coronavirus outbreak since its onset. We are continually looking for insights to share in the hope that they can help people or companies through this difficult time.
Press Release Medical Technology and Software
Leading Australian CRO Avance Clinical today detailed the top reasons its APAC biotechs selected Australia for their early phase clinical trials, based on client onboarding feedback. Avance is a specialist Australian CRO with more than 20-years of early phase clinical trials expertise.
Adelaide, AUS - (ACN Newswire) - Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.
With the number of Coronavirus cases increasing every day, it is evident that the entire world is struggling to triumph over this deadly disease. While the top health organizations are aiding funds to facilitate research, many believe that the artificial intelligence might help in decelerating the crisis.
There is no other segment than coronavirus news that is being discussed widely over all mediums. Be it print media or news channels and even social media handles. Coronavirus has sting such a large number of people over the globe. That every other news which is getting published is now getting replaced by this pandemic news that has taken the lives of 34,000 souls.
Dyadic International, Inc. ("Dyadic" or the "Company") (NASDAQ:DYAI), a global biotechnology company focused on further improving and applying its proprietary C1 gene expression platform to accelerate development, lower production costs and improve the performance of biologic vaccines, drugs, and other biologic products, at flexible commercial scales, today announced that it has entered into a nonexclusive research collaboration with WuXi Biologics, a leading global open-access biologics technology platform company and Contract Development and Manufacturing Organization (CDMO).
Award-winning global digital patient recruitment Platform GeoMap Clinical said it was making video visits (telemedicine, telehealth), instantly available to patients with services like Zoom, WhatsApp, Google, Skype and Facebook, via SMS messages and email to screened eligible patients.
On March 6th Azabu Insights proposed a theory that coronavirus seemed to be spreading faster in cold countries than in warm countries. We followed this up with an update on March 11th showing that at that time the data was showing ninety-eight percent of the cases were all in cold countries.
NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a leader in the development of highly effective antiviral therapies based on a novel nanomedicines platform, is providing an update on its efforts towards drug development for the current novel coronavirus SARS-CoV-2 that causes COVID-19.
Both compounds block integral viral mechanisms for SARS-CoV-2 replication and infection
State-owned hospitals, under the Indonesian Healthcare Corporation (IHC) Pertamedika, will help the government handle the spread of coronavirus (COVID-19), including through treating and isolating patients at their facilities, State-Owned Enterprises Minister Erick Thohir stated.
Medical chronology is a document that presents relevant details of medical events on a timeline. Typically medical chronologies list category of service, the healthcare provider, date of visit and outcome of the medical event. Generally, a chronology itself is of limited use unless hyperlinked references are provided into the medical record.
ASX-listed Holista CollTech (ASX:HCT, "Holista") announced today a strong spike in demand in Malaysia for it all-natural disinfectant spray NatShield(TM) Sanitizer, that contains the powerful Path-Away(R) anti-microbial compound. The increased demand follows the recent outbreak of the deadly coronavirus originating from Wuhan, China.
Novotech CRO the largest biotech CRO in the Asia-Pacific said the region has had a record year for number of studies, experienced world-class sites and investigators, and patient enrolment.
Flagship Product Tauri-Gum(TM) Successfully Listed on Alibaba.com
Before we move to the great healthcare platform: MYCARE – let’s understand what is telehealth and how it transforms the healthcare arena?
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce last evening (December 19, 2019) that Lyfted Farms, Inc. ("Lyfted or Lyfted Farms") a wholly owned subsidiary of TransCanna received unanimous recommendation from the Stanislaus County Planning Commission to recommend to the Board of Supervisors the approval of the Daly Project.
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that SolDaze Snacks won first place for their tropical mango fruit bites and third place for their strawberry mango fruit bites in the CBD edible category at the 2019 Emerald Cup. SolDaze has won multiple times at the Emerald Cup, including in 2018 for its THC edibles.
TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) ("TransCanna" or the "Company") is pleased to announce that it has developed a comprehensive strategy for a four phase expansion of sales and fulfillment in the Northern and Southern California markets for all TransCanna brands.
Highlights - Formulation makes water soluble cannabidiol (CBD) oil up to 40 times better absorbed - Taste masking technology increases acceptance in oral pharma and food formulations - Project Leader is Dr Roscoe Moore Jr - retired United States Assistant Surgeon General - an advocate of evidenced based CBD - Technology could apply to most fat-soluble medications and foods, including curcumin and Vitamin D - Commercialisation by licensing begins in North America in 2020
Novaliq GmbH, a pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiangsu Hengrui Medicine Co., Ltd. (SSE: 600276), a fully integrated biopharmaceutical company based in China, announce today the closing of an exclusive license agreement to develop, manufacture and commercialize the innovative, water-free drugs NOV03 and CyclASol(R) for the treatment of dry eye disease in the People's Republic of China (including mainland China, Hong Kong, Macau and Taiwan).